Heterocyclic Building Blocks

Sulfur-Containing Heterocycles

Thienopyridine Derivatives Thiophene Derivatives

Indole Derivatives

Spiro cyclic Heterocycles

Bridged Bicyclic Heterocycles

Pidine Derivatives

Pyridine Derivatives

Isoquinoline Derivatives

Fused Bicyclic Heterocycles

Pyridine Derivatives

Pyrazole Derivatives

Sulfur-Containing Heterocycles

Thiophene Derivatives

Fused Bicyclic Heterocycles

Azepine Derivatives

Benzazepines

Pyridazine Derivatives

Fused Bicyclic Heterocycles

Pyrazolo-pyrimidine Derivatives Isoquinoline Derivatives Pyrrolopyrimidine Derivatives Pyrrolopyridine Derivatives Imidazopyridine Derivatives Pyrazolo-pyridine Derivatives

Sulfur-Containing Heterocycles

Spiro cyclic Heterocycles

Coumarin Derivatives

Pyrrole Derivatives

Benzoxaborole Derivatives

Pyridone Derivatives

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Kinase Inhibitors

En Inhibitor Intermediates

Kinase Inhibitors

Alkylating Agents

Cytotoxic Natural Products

Neurological Intermediates

Anticonvulsants

Cardiovascular Intermediates

Cardiac Glycosides

Vasodilator Intermediates

Angiotensin II Receptor Blockers

Calcium Channel Blockers

Organic Synthesis Intermediates

Nitrile Intermediates

Heterocyclic Building Blocks

Quinoline Derivatives

Aromatic Alcohols

Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Halogenated Aromatic Alcohols

Ketone Intermediates

Antidiabetic Intermediates

Antimalarial Intermediates

Amide Intermediates

Benzamide Derivatives

Enzyme Inhibitor Intermediates

Kinase Inhibitors

Carbonic Anhydrase Inhibitors

Nitro Aromatic Derivatives

Drug Discovery Reagents

Antimalarial Intermediates

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Sulfonamide Intermediates

Neurological Research Reagents

Heterocyclic Building Blocks

Antihistamine Intermediates

Phenolic Intermediates

Halogenated Phenols

Aliphatic Carboxylic Acid Derivatives

Malonic Acid Derivatives

Drug Delivery Intermediates

Surface Modification Reagents

REAGENT

4-Ethyl-1,4,7,8-tetrahydro-3H,10H-spiro[pyrano[3,4-f]indolizine-6,2'-[1,3]dioxolane]-3,10-dione

95%

CAS:127318-97-2

Formula:C₁₅H₁₇NO₅

MW:291.30 g/mol

฿40,090.00

ข้อมูล

REAGENT

4-Ethyl-4-hydroxy-1,4,7,8-tetrahydro-3H,10H-spiro[pyrano[3,4-f]indolizine-6,2'-[1,3]dioxolane]-3,10-dione

95%

CAS:102978-41-6

Formula:C₁₅H₁₇NO₆

MW:307.30 g/mol

฿10,800.00

ข้อมูล

REAGENT

Ethyl 2-(6'-cyano-5'-oxo-3',5'-dihydro-2'H-spiro[[1,3]dioxolane-2,1'-indolizin]-7'-yl)acetate

95%

CAS:58610-65-4

Formula:C₁₅H₁₆N₂O₅

MW:304.30 g/mol

฿4,930.00

ข้อมูล

REAGENT

Ethyl2-(Hydroxymethyl)-4-methylthiazole-5-carboxylate

95%

CAS:1865219-65-3

Formula:C₈H₁₁NO₃S

MW:201.24 g/mol

฿37,050.00

ข้อมูล

REAGENT

(E)-4-(4-Hydroxyphenyl)but-3-en-2-one

98%

CAS:22214-30-8

Formula:C₁₀H₁₀O₂

MW:162.19 g/mol

฿33,450.00

ข้อมูล

REAGENT

Euphohelioscopin A

Analyze the control, ≥96% (HPLC)

CAS:87064-61-7

Formula:C₃₀H₄₂O₆

MW:498.65 g/mol

฿51,200.00

ข้อมูล

REAGENT

5-Ethynyl-2-fluorobenzaldehyde

97%

CAS:1440535-11-4

Formula:C₉H₅FO

MW:148.14 g/mol

฿3,980.00

ข้อมูล

REAGENT

1-Ethyl-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide

98%

CAS:29097-12-9

Formula:C₉H₁₂N₂O₃

MW:196.20 g/mol

฿15,500.00

ข้อมูล

REAGENT

Ethyl 1-(2-((tert-butoxycarbonyl)amino)ethyl)-3-(4-chlorophenyl)-4-(((trifluoromethyl)sulfonyl)oxy)-1H-pyrazole-5-carboxylate

≥95%

CAS:1956364-75-2

Formula:C₂₀H₂₃ClF₃N₃O₇S

MW:541.93 g/mol

฿10,690.00

ข้อมูล

REAGENT

Ethyl 6-hydroxy-1,5-naphthyridine-3-carboxylate

98%

CAS:2007920-40-1

Formula:C₁₁H₁₀N₂O₃

MW:218.21 g/mol

฿19,060.00

ข้อมูล

ตะกร้า

ไม่มีสินค้า

Subtotal: 0.00

รวมทั้งสิ้น 0.00 THB

ตะกร้า สั่งซื้อ

Researcher Network คุณอยู่ในองค์กรการวิจัยใดๆ หรือไม่? ใช้อีเมลองค์กรของคุณเพื่อตรวจสอบสิทธิ์และข้อกำหนดใบกำกับภาษีขององค์กร ดูรายละเอียด